IL-1α, IL-1β and TNF-α secretion during in vivo/ex vivo cellular interactions with titanium and copper

Biomaterials

Volumn 24, Issue 3, 2003, Pages 461-468

  Suska, F ^a   Esposito, M ^a   Gretzer, C ^a   Kalltorp M ^a   Tengvall, P ^b   Thomsen, P ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Chemotaxis; Copper; Cytokine; Inflammation; Titanium

Indexed keywords

BIOCHEMISTRY; BIOCOMPATIBILITY; CELLS; COPPER; TISSUE; TITANIUM; TOXIC MATERIALS; TUMORS;

SECRETIONS;

BIOMATERIALS;

BIOMATERIAL; COPPER; INTERLEUKIN 1; ISOPROTEIN; TITANIUM; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; ANIMAL; BIOSYNTHESIS; CHEMOTAXIS; INFLAMMATION; METABOLISM; SECRETION; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; BIOCOMPATIBLE MATERIALS; CHEMOTAXIS; COPPER; CYTOKINES; DNA; FEMALE; INFLAMMATION; INTERLEUKIN-1; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TITANIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037290141     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(02)00359-9     Document Type: Article

References (63)

1. Anderson J.M. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol. 2(3 Suppl.):1993;33S-41S.
2. Thomsen P., Gretzer C. Macrophage interactions with modified material surfaces. Curr Opin Solid State Mater. 5:2001;163-176.
3. Dinarello C.A. Role of pro- and anti-inflammatory cytokines during inflammation. experimental and clinical findings J Biol Regul Homeost Agents. 11(3):1997;91-103.
4. Dinarello C.A. Proinflammatory cytokines. Chest. 118(2):2000;503-508.
5. Lonnemann G., Endres S., Van der Meer J.W., Cannon J.G., Koch K.M., Dinarello C.A. Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells. Eur J Immunol. 19(9):1989;1531-1536.
6. Sun J.-S., Lin F.-H., Tsuang Y.-H., Chen L.-T., Hong R.-C., Chang W.H.-S., Liu H.-C. Effect of anti-inflammatory medication on monocyte response to titanium particles. J Biomed Mater Res. 52:2000;509-516.
7. Granchi D., Ciapetti G., Stea S., Savarino L., Filippini F., Sudanese A., Zinghi G., Montanaro L. Cytokine release in mononuclear cells of patients with Co-Cr hip prosthesis. Biomaterials. 20(12):1999;1079-1086.
8. Al Saffar N., Revell P.A. Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants. a potential role in osteolysis Br J Rheumatol. 33(4):1994;309-316.
9. Källtorp M., Oblogina S., Jacobsson S., Karlsson A., Tengvall P., Thomsen P. In vivo cell recruitment, cytokine release and chemiluminescence response at gold, and thiol functionalized surfaces. Biomaterials. 20(22):1999;2123-2137.
10. Fisher G., Sayre G.P., Bickford R.G. Histologic changes in the cat's brain after introduction of metallic and plastic coated wire used in electro-encephalography. Staff Meetings Mayo Clin. 32(1):1957;14.
11. Chusid J.G., Kapeloff L.M. Epileptogenic effects of pure metals implanted in motor cortex of monkeys. J Appl Physiol. 17:1962;697.
12. Sights W.P., Bye R.J. The fate of retained intracerebral shotgun pellets. An experimental study. J Neurosurg. 33(6):1970;646-653.
13. Zierold A.A. Reaction of bone to various metals. Arch Surg. 9:1924;365-412.
14. Wigle R.L. The reaction of copper and other projectile metals in body tissues. J Trauma. 33(1):1992;14-18.
15. Keller J.C., Kaminski E.J. Toxic effects of Cu implants on liver. Fundam Appl Toxicol. 4(5):1984;778-783.
16. Keller J.C., Marshall G.W., Kaminski E.J. An in vivo method for the biological evaluation of metal implants. J Biomed Mater Res. 18(7):1984;829-844.
17. McNamara A., Williams D.F. Enzyme histochemistry of the tissue response to pure metal implants. J Biomed Mater Res. 18:1984;185-206.
18. Labedzka M., Gulyas H., Schmidt N., Gercken G. Toxicity of metallic ions and oxides to rabbit alveolar macrophages. Environ Res. 48(2):1989;255-274.
19. Bumgardner J.D., Lucas L.C., Alverson M.W., Tilden A.B. Effects of copper-based dental casting alloys on two lymphocyte cell lines and the secretion of interleukin 2 and IgG. Dent Mater. 9(2):1993;85-90.
20. Steinebach O.M., Wolterbeek H.T. Effects of copper on rat hepatoma HTC cells and primary cultured rat hepatocytes. J Inorg Biochem. 53(1):1994;27-48.
21. Wataha J.C., Hanks C.T., Sun Z. In vitro reaction of macrophages to metal ions from dental biomaterials. Dent Mater. 11(4):1995;239-245.
22. Schmalz G., Schuster U., Schweikl H. Influence of metals on IL-6 release in vitro. Biomaterials. 19(18):1998;1689-1694.
23. Yamamoto A., Honma R., Sumita M. Cytotoxicity evaluation of 43 metal salts using murine fibroblasts and osteoblastic cells. J Biomed Mater Res. 39:1998;331-340.
24. Eichhorn G.L., Berger N.A., Butzov J.J., Clark P., Heim J., Pitha J., Richardson C., Rifkind J.M., Shin Y., Tarien E. Some effects of metal ions on the structure and function of nucleic acids. Adv Exp Med Biol. 40:1973;43-66.
25. Niyogi S.K., Feldman R.P., Hoffman D.J. Selective effects of metal ions on RNA synthesis rates. Toxicology. 22(1):1981;9-21.
26. Zhai Q., Ji H., Zheng Z., Yu X., Sun L., Liu X. Copper induces apoptosis in BA/F3beta cells. bax, reactive oxygen species, and NFkappaB are involved J Cell Physiol. 184(2):2000;161-170.
27. Cox J.L., Harrison S.D. Jr. Correlation of metal toxicity with in vitro calmodulin inhibition. Biochem Biophys Res Commun. 115(1):1983;106-111.
28. Holgers K.-M., Esposito M., Källtorp M., Thomsen P. Titanium in soft tissues. Brunette D., Tengvall P., Textor P., Thomsen P. Titanium in medicine. 2001;513-560 Springer, Heidelberg, Berlin.
29. Suska F., Källtorp M., Esposito M., Gretzer C., Tengvall P., Thomsen P. In vivo/ex vivo cellular interactions with titanium and copper. J Mater Sci: Mater Med. 12:2001;939-944.
30. Labarca C., Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 102(2):1980;344-352.
31. Hunt J.A., Remes A., Williams D.F. Stimulation of neutrophil movement by metal ions. J Biomed Mater Res. 26(6):1992;819-828.
32. Hujanen E.S., Seppa S.T., Virtanen K. Polymorphonuclear leukocyte chemotaxis induced by zinc, copper and nickel in vitro. Biochim Biophys Acta. 1245(2):1995;145-152.
33. Broeckaert F., Buchet J.P., Huaux F., Lardot C., Lison D., Yager J.W. Reduction of the ex vivo production of tumor necrosis factor alpha by alveolar phagocytes after administration of coal fly ash and copper smelter dust. J Toxicol Environ Health. 51(2):1997;189-202.
34. Blaine T.A., Rosier R.N., Puzas J.E., Looney R.J., Reynolds P.R., Reynolds S.D., O'Keefe R.J. Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Joint Surg Am. 78(8):1996;1181-1192.
35. Horowitz S.M., Gonzales J.B. Inflammatory response to implant particulates in a macrophage/osteoblast coculture model. Calcif Tissue Int. 59(5):1996;392-396.
36. Rader C.P., Sterner T., Jakob F., Schutze N., Eulert J. Cytokine response of human macrophage-like cells after contact with polyethylene and pure titanium particles. J Arthroplasty. 14(7):1999;840-848.
37. Robinson T.M., Manley P.A., Sims P.A., Albrecht R., Darien B. Cytokine and eicosanoid production by cultured human monocytes exposed to titanium pariculate debris. Microsc Microanal. 5:1999;344-351.
38. Kohilas K., Lyons M., Lofthouse R., Frondoza C.G., Jinnah R., Hungerford D.S. Effect of prosthetic titanium wear debris on mitogen-induced monocyte and lymphoid activation. J Biomed Mater Res. 47(1):1999;95-103.
39. Nakashima Y., Sun D.H., Trindade M.C., Maloney W.J., Goodman S.B., Schurman D.J., Smith R.L. Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J Bone Joint Surg Am. 81(5):1999;603-615.
40. Glant T.T., Jacobs J.J. Response of three murine macrophage populations to particulate debris. bone resorption in organ cultures J Orthop Res. 12(5):1994;720-731.
41. Ren Y., Savill J. Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J Immunol. 154(5):1995;2366-2374.
42. Granchi D., Cenni E., Ciapetti G., Savarino L., Stea S., Gamberini S., Gori A., Pizzoferrato A. Cell death induced by metal ions. necrosis or apoptosis? J Mater Sci Mater Med. 9:1998;31-37.
43. Flad H.D., Grage-Griebenow E., Scheuerer B., Durrbaum-Landmann I., Petersen F., Brandt E., Fleischer J., Baran J., Pryjma J., Ernst M. The role of cytokines in monocyte apoptosis. Res Immunol. 149(7-8):1998;733-736.
44. Sitrin R.G., Pan P.M., Srikanth S., Todd R.F. Third fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J Immunol. 161(3):1998;1462-1470.
45. Gretzer C., Werthen M., Thomsen P. Apoptosis and cytokine release in human monocytes cultured on polystyrene and fibrinogen coated polystyrene surfaces. Biomaterials. 23(7):2002;1639-1648.
46. Fan S.T., Edgington T.S. Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest. 87(1):1991;50-57.
47. Fan S.T., Edgington T.S. Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes. J Immunol. 150(7):1993;2972-2980.
48. Hong J., Andersson J., Nilsson Ekdahl K., Elgue G., Axen N., Larsson R., Nilsson B. Titanium is a highly thrombogenic biomaterial. possible implications for osteogenesis Thromb Haemost. 82:1999;58-64.
49. Gerard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med. 177(2):1993;547-550.
50. Marchant A., Bruyns C., Vandenabeele P., Ducarme M., Gerard C., Delvaux A., De Groote D., Abramowicz D., Velu T., Goldman M. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol. 24(5):1994;1167-1171.
51. Clarke C.J., Hales A., Hunt A., Foxwell B.M. IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. Eur J Immunol. 28(5):1998;1719-1726.
52. Opal S.M., DePalo V.A. Anti-inflammatory cytokines. Chest. 117(4):2000;1162-1172.
53. Opal S.M., Wherry J.C., Grint P. Interleukin-10. potential benefits and possible risks in clinical infectious diseases Clin Infect Dis. 27(6):1998;1497-1507.
54. Joyce D.A., Gibbons D.P., Green P., Steer J.H., Feldmann M., Brennan F.M. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol. 24(11):1994;2699-2705.
55. Dickensheets H.L., Freeman S.L., Smith M.F., Donnelly R.P. Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes. Blood. 90(10):1997;4162-4171.
56. Baeuerle P.A., Baltimore D. NF-kappa B. ten years after Cell. 87(1):1996;13-20.
57. Kurt-Jones E.A., Beller D.I., Mizel S.B., Unanue E.R. Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci USA. 82(4):1985;1204-1208.
58. Hazuda D.J., Lee J.C., Young P.R. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J Biol Chem. 263(17):1988;8473-8479.
59. Mosley B., Urdal D.L., Prickett K.S., Larsen A., Cosman D., Conlon P.J., Gillis S., Dower S.K. The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J Biol Chem. 262(7):1987;2941-2944.
60. Hogquist K.A., Unanue E.R., Chaplin D.D. Release of IL-1 from mononuclear phagocytes. J Immunol. 147(7):1991;2181-2186.
61. Stevenson F.T., Torrano F., Locksley R.M., Lovett D.H. Interleukin 1. the patterns of translation and intracellular distribution support alternative secretory mechanisms J Cell Physiol. 152(2):1992;223-231.
62. Watanabe N., Kobayashi Y. Selective release of a processed form of interleukin 1 alpha. Cytokine. 6(6):1994;597-601.
63. Rosenwasser L.J. Biologic activities of IL-1 and its role in human disease. J Allergy Clin Immunol. 102(3):1998;344-350.